摘要 |
The present invention is concerned with methods and compositions for use in the medical art and relates to the use of an activin neutraliser or a mixture thereof for the manufacture of a medicament for the prophylaxis and / or therapy of diseases associated with aberrant "Host Defence Response" activation in a subject. The present invention provides activin neutralisers in the form of soluble ActRII polypeptides, or a fragment(s) or analogue thereof; follistatin, follistatin-like 3 protein, or a fragment(s) or analogue thereof; low molecular weight organic compounds; antibodies raised against either activin-A, activin-B, or activin receptors or immunogenic portions thereof; and antisense nucleic acids, ribozymes, triplex agents, siRNAs and miRNAs. Also provided are pharmaceutical compositions, comprising a therapeutically effective or prophylactically effective amount of at least one activin neutraliser in admixture with pharmaceutically acceptable carriers, adjuvants and / or diluents. Also provided are methods for the prophylaxis and / or therapy of diseases (including a combination of therapies) associated with said aberrant Host Defence Response activation. Diseases that may be treated according to the method of the present invention include ALI/ARDS, sepsis and COPD. |
申请人 |
BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS;SIDERAS, PASCHALIS;APOSTOLOU, EIRINI;STAVROPOULOS, ATHANASIOS;SOUNTOULIDIS, ALEXANDROS;XIRAKIA, CHAROULA;PROTOPAPADAKIS, EVDOKIA;GIAGLIS, STAVROS;RITVOS, OLLI;ANDREAKOS, EVANGELOS |
发明人 |
SIDERAS, PASCHALIS;APOSTOLOU, EIRINI;STAVROPOULOS, ATHANASIOS;SOUNTOULIDIS, ALEXANDROS;XIRAKIA, CHAROULA;PROTOPAPADAKIS, EVDOKIA;GIAGLIS, STAVROS;RITVOS, OLLI;ANDREAKOS, EVANGELOS |